Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3065

Actual shortage: 232 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2809 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ANAFRANIL 25MG TABLET Resolved 2024-03-15 2024-03-22 222473
APO-SERTRALINE 25MG CAPSULE Resolved 2024-03-15 2024-05-03 222481
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2024-04-12 2024-05-31 224977
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2024-05-10 2024-05-31 227717
APO-HYDRALAZINE 25MG TABLET TABLET Actual shortage 2024-05-24 2024-05-24 228804
APO-ATOMOXETINE 25MG CAPSULE Anticipated shortage 2024-05-30 2024-05-30 229164
APO-NAPRO-NA 275MG TABLET Resolved 2018-05-15 2018-10-05 49499
APO-NAPRO-NA 275MG TABLET Resolved 2022-06-06 2022-08-22 162077
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-25 2017-11-03 16938
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-05-24 37963
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-04 2018-08-01 54285
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-18 2019-07-17 69918
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-05 2021-02-16 133382
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-16 2021-09-27 137581
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-14 159719
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2023-04-27 185927
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-10 208400
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-12 212371

Showing 1661 to 1680 of 3065

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DILTIAZ TZ 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1069
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-SUCRALFATE - TAB 1G 1G TABLET Discontinued 2018-09-10 2018-09-15 61033
APO PREDNISONE TAB 1MG USP 1MG TABLET Discontinued 2017-03-13 2017-03-13 1056
APO-TERAZOSIN 1MG TABLET Discontinued 2017-03-30 2018-02-05 4745
APO-CILAZAPRIL 1MG TABLET To be discontinued 2018-09-07 2018-12-28 60373
APO-LORAZEPAM 1MG TABLET Discontinued 2018-09-07 2018-10-05 60594
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2018-09-08 2018-09-08 60753
APO-TOLTERODINE 1MG TABLET Discontinued 2018-09-08 2019-01-17 60822
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260
APO-OLANZAPINE 2.5MG TABLET Discontinued 2017-03-30 2018-02-05 4738
APO-ZOLMITRIPTAN 2.5MG TABLET Discontinued 2018-02-26 2018-02-26 40960
APO GLYBURIDE TAB 2.5MG 2.5MG TABLET Discontinued 2018-09-07 2019-07-04 60515
APO-MEDROXY TABLETS 2.5MG TABLET Discontinued 2018-09-07 2018-09-15 60609
APO-ZOLMITRIPTAN RAPID 2.5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-09-08 2018-09-15 60867
APO-ZOLMITRIPTAN 2.5MG TABLET Discontinued 2019-01-03 2019-01-03 71072
APO-SULIN TAB 200MG 200MG TABLET Discontinued 2017-03-13 2017-03-13 1172
APO-CELECOXIB 200MG CAPSULE Discontinued 2018-09-07 2021-01-21 60366
APO-HYDROXYQUINE 200MG TABLET Discontinued 2018-09-07 2018-10-05 60524
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711

Showing 141 to 160 of 356